Published: 2020-03-25

A prospective interventional study of intra-caesarean copper intrauterine contraceptive devices insertion in a teaching hospital in a rural medical college in Telangana, India

Gillella Vijayalakshmi, Kavitha Kothapally, Uma Bhashyakarla, Vasantha Kavati


Background: Providing quality contraceptive services to women is essential for achieving maternal and child health. Objective of this study was to evaluate the efficacy of intra-caesarean insertion of copper IUCDs as postpartum contraception. To study the side effects of intra caesarean copper device. To study the continuation rates of intra-caesarean copper IUCDs. To study the acceptability of intra-caesarean copper IUCD as immediate postpartum contraceptive.

Methods: The prospective study was undertaken at Bhaskar medical college and general hospital, Yenkepally, Moinabad, Telangana, between January 2016 and March 2018 after ethical committee clearance. About 60 pregnant women were enrolled into the study after an informed written consent regarding the procedure, benefits and complications and the need for follow up for at least one year. Copper T 380A/multiload copper 375 was inserted into the uterine cavity after delivery of the placenta and membranes during caesarean section. Patients were followed up at 6 weeks, 6 months and one-year intervals for any complaints, visibility of threads and for ultrasound examination for position of copper IUCDs in the uterus. Data analysis was done using Microsoft excel 2016.

Results: Nearly 48.33% continued intra-caesarean copper IUCDs for more than 1 year. 70% did not have any complaints. 86.67% came for more than one follow-up visit. 47% had copper IUD threads visible by one year. No case of perforation either during insertion or during continuation was noted. None conceived with copper IUCD in situ. Removal of copper IUCD was also easy and none required hysteroscopic removal.

Conclusions: Intra-caesarean copper IUCD insertion is a safe and effective long acting reversible contraceptive method in the postpartum period.


Continuation of contraception, Intra-caesarean copper IUCDs, Safety, Visibility of threads

Full Text:



Post-partum IUCD reference manual; Family Planning Division Ministry of Health and Family Welfare Government of India, 2010. Available at: Accessed on 10th January 2020.

Levi EE, Stuart GS, Zerden ML, Garrett JM, Bryant AG. Intrauterine device placement during cesarean delivery and continued use 6 months postpartum: a randomized controlled trial. Obstet Gynecol. 2015;126(1):5-11.

Mishra S. Tale of the tails, the missing postpartum IUCD strings. J Obstet Gynaecol India. 2017;67(3):202-7.

Katheit G, Agarwal J. Evaluation of post-placental intrauterine device (PPIUCD) in terms of awareness, acceptance, and expulsion in a tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2013;2(4):539-43.

Hooda R, Mann S, Nanda S, Gupta A, More H, Bhutani J. Immediate postpartum intrauterine contraceptive device insertions in caesarean and vaginal deliveries: a comparative study of follow-up outcomes. Inter J Reprod Med. 2016:Article ID 7695847:5.

Valliappan A, Dorairajan G, Chinnakali P. Postpartum intrauterine contraceptive device: knowledge and factors affecting acceptance among pregnant/parturient women attending a large tertiary health center in Puducherry, India. Int J Adv Med Health Res. 2017;4(2):69-74.

Agarwal K, Dewan R, Mittal P, Aggarwal A. Visibility of strings after postplacental intracesarean insertion of CuT380A and Cu375 intrauterine contraceptive device: a randomized comparative study. The J Obstet Gynecol India. 2017;67(5):324-9.

Goldstuck ND, Steyn PS. Insertion of intrauterine devices after cesarean section: a systematic review update. Inter J Women's Health. 2017;9:205.

Kumar S, Sethi R, Balasubramaniam S, Charurat E, Lalchandani K, Semba R, Sood B. Women’s experience with postpartum intrauterine contraceptive device use in India. Reprod Health. 2014;11(1):32.

Dewan R, Bajaj B, Kapoor G, Pardeshi GS. Changing scenario in indian contraceptive methods: a glimpse through a tertiary hospital statistic. The J Obstet Gynecol India. 2019;69(5):462-6.

Singh S, Malik R, Ahalawat R, Taneja BK. Evaluation of efficacy, expulsion and safety of post-placental and intra-cesarean insertion of intrauterine contraceptive devices. Int J Reprod Contracept Obstet Gynecol. 2017;4(6):2005-9.

Ramya KS, Meena TS, Mothilal R. A comparative study of PPIUCD acceptance between primiparaous and multiparaous women in a tertiary care hospital in Tamil Nadu. Int J Reprod Contracept Obstet Gynecol. 2017;6(8):3569-72.

Gupta P, Gupta MM, Sharma R. IUCD (copper T 380 A) as a contraceptive method in Indian context: Acceptability, safety and efficacy. JOGI. 2018;68(2):129-35.

Tripathi U, Sahu D. Outcome of immediate postpartum insertion of IUCD - A prospective study, Indian J Obstet Gynecol Res. 2018;5(4):511-5.

Sharma M, Joshi S, Nagar O, Sharma A. Determinants of intrauterine contraceptive device discontinuation among Indian women. The J Obstet Gynecol India. 2014;64(3):208-11.

Sharma A, Gupta V. A study of awareness and factors affecting acceptance of PPIUCD in south-East Rajasthan. Int J Comm Med Public Heal. 2017;4(8):2706-10.

Moniz M, Chang T, Heisler M, Dalton VK. Immediate postpartum long acting reversible contraception: the time is now. Contracept. 2017;95(4):335.